Breaking News

You are here » Indian-Commodity  :  Top News  :  Bombay Dyeing acquires 4.32% stake in Archway

06-Sep2016

Bombay Dyeing acquires 4.32% stake in Archway

Bombay Dyeing & Manufacturing Company (BDMC) has acquired 4.32% of equity share capital amounting 2,24,400 equity shares of Archway Investment Company (Archway) from minority shareholders. By this acquisition, Archway has become wholly owned subsidiary of BDMC.

Bombay Dyeing and Manufacturing Company is a holding company that is engaged in finishing of cotton and blended cotton textiles; manufacturing of bedding, quilts, pillows and sleeping bags; real estate activities, and manufacturing of polyester Staple Fiber (PSF).




Related News

View all news

Crude oil futures extend losses on Thursday

Extending previous session losses, crude oil futures ended lower on Thursday due to a sharp jump in US crude inventories last week and on demand growth concerns. The Energy Information Administration's......

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Copper futures end lower on Thursday

Copper futures ended lower on Thursday, following Chinese stock markets lower on the prospect of slowing global economic growth. Further, concerns over US interest rates and the US-China trade war too......

Top News

View all news

Reliance Power's arm wins arbitration award against NACC

Reliance Power's Wholly Owned Subsidiary -- Sasan Power has won an arbitration award against North American Coal Corporation (NACC). This is a major milestone in this arbitration with the award received......

Tata Steel's arm signs agreement to divest entire stake in Black Ginger 461

Tata Steel's wholly owned indirect subsidiary -- TS Global Minerals Holdings Pte has entered into an agreement to divest its entire stake in its wholly owned step down subsidiary Black Ginger 461 Pty which......

Biocon, Mylan N.V. receive positive approval for Ogivri

Biocon and Mylan N.V. have been issued a positive opinion recommending approval of Ogivri, a biosimilar to Roche's Herceptin (trastuzumab) by the European Medicines Agency's Committee for Medicinal Products......